Analysis of the impact and burden of illness of adult chronic ITP in the US

Current Medical Research and Opinion

Volumn 25, Issue 12, 2009, Pages 2961-2969

  Saleh, Mansoor N ^a   Fisher, Maxine ^b   Grotzinger, Kelly M ^c  

^a Georgia Cancer Specialists   (United States)

^b HEALTHCORE INC   (United States)

^c GLAXOSMITHKLINE   (United States)

Author keywords

Chronic; Cost of illness; Healthcare costs; Idiopathic thrombocytopenic purpura; Thrombocytopenia

Indexed keywords

ANALGESIC AGENT; ANTIBIOTIC AGENT; ANTIDEPRESSANT AGENT; ANTIHYPERTENSIVE AGENT; AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DANAZOL; IMMUNOGLOBULIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RITUXIMAB;

ADULT; AGED; ARTICLE; AUTOIMMUNE DISEASE; BLEEDING; BLOOD TRANSFUSION; CELL DESTRUCTION; COHORT ANALYSIS; COMORBIDITY; DEMOGRAPHY; EMERGENCY WARD; FEMALE; HEALTH CARE; HEALTH CARE COST; HEALTH CARE MANAGEMENT; HEALTH CARE UTILIZATION; HOSPITAL ADMISSION; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; MAJOR CLINICAL STUDY; MALE; MANAGED CARE; MEDICAL CARE; PATIENT CARE; PREVALENCE; SEX RATIO; SPLENECTOMY; THROMBOCYTE; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; THROMBOCYTOPOIESIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHRONIC DISEASE; COST OF ILLNESS; FEMALE; HEALTH CARE COSTS; HEALTH RESOURCES; HUMANS; MALE; MIDDLE AGED; PREVALENCE; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; UNITED STATES; YOUNG ADULT;

EID: 72549090545     PISSN: 03007995     EISSN: 14734877     Source Type: Journal    
DOI: 10.1185/03007990903362388     Document Type: Article

References (30)

1. Woods Jr VL, Oh EH, Mason D, et al. Autoantibodies against the platelet glycoprotein IIb/IIIa complex in patients with chronic ITP. Blood 1984;63:368-375 (Pubitemid 14188884)
2. Woods Jr VL, Kurata Y, Montgomery RR, et al. Autoantibodies against platelet glycoprotein Ib in patients with chronic immune thrombocytopenic purpura. Blood 1984;64:156-160 (Pubitemid 14083869)
3. Cines DB, Bussel JB, McMillan RB, et al. Congenital and acquired thrombocytopenia. Hematology (Am Soc Hematol Educ Program). Washington, DC: American Society of Hematology, 2004:390-406
4. McMillan R, Durette C. Long-term outcomes in adults with chronic ITP after splenectomy failure. Blood 2004;104:956-960 (Pubitemid 39038013)
5. Neylon AJ, Saunders PW, Howard MR, et al.; on behalf of the Northern Region Haematology Group. Clinically significant newly presenting autoimmune thrombocytopenic purpura in adults: a prospective study of a populationbased cohort of 245 patients. Br J Haematol 2003;122:966-974
6. Cines DB, Blanchette MB. Immune thrombocytopenic purpura. N Engl J Med 2002;346:995-1008
7. George JN. Management of patients with refractory immune thrombocytopenic purpura. J Thromb Haemost 2006;4:1664-1672 (Pubitemid 44144790)
8. Cines DB, Bussel JB. How I treat idiopathic thrombocytopenic purpura (ITP). Blood 2005;106:2244-2251 (Pubitemid 41510792)
9. Provan A, Newland A. Idiopathic thrombocytopenic purpura in adults. J Pediatr Hematol Oncol 2003;25(Suppl 1):S34-8
10. Portielje JEA, Westerndorp RGJ, Kluin-Nelemans HC, et al. Morbidity and mortality in adults with idiopathic thrombocytopenic purpura. Blood 2001;97:2549-2554
11. British Committee for Standards in Haematology. General Haematology Task Force. Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy. Br J Haematol 2003;120:574-596
12. American Society of Hematology. ITP Practice Guideline Panel. Diagnosis and treatment of idiopathic thrombocytopenic purpura: recommendations of the American Society of Hematology. Ann Intern Med 1997;126:319-326
13. George JN, Woolf SH, Raskob GE, et al. Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood 1996;88:3-40
14. Segal JB, Powe NR. Prevalence of immune thrombocytopenia: analyses of administrative data. J Thromb Haemost 2006;4:2377-2383
15. Rodeghiero F, Stasi R, Gernsheimer T, et al. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood 2009;113:2386-2393
16. George JN, Woolf SH, Raskob GE. Idiopathic thrombocytopenic purpura: a guideline for diagnosis and management of children and adults. American Society of Hematology. Ann Med 1998;30:38-44
17. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992;45:613-619
18. Fogarty PF, Segal JB. The epidemiology of immune thrombocytopenic purpura. Curr Opin Hematol 2007;14:515-519
19. Feudjo-Tepie MA, Robinson NJ, Bennett D. Prevalence of diagnosed chronic immune thrombocytopenic purpura in the US: analysis of a large US claim database: a rebuttal [comment on: Segal JB, Powe NR. In: J Thromb Haemost 2006;4:2377-83]. J Thromb Haemost 2008;6:711-712
20. Frederiksen H, Schmidt K. The incidence of idiopathic thrombocytopenic purpura in adults increases with age. Blood 1999;94:909-913 (Pubitemid 29361821)
21. Diz-Kucukkaya R, Gushiken FC, Lopez JA. Thrombocytopenia. In: Lichtman MA, Beutler E, Kipps TJ, et al., eds. Williams Hematology, 7th edn. New York: McGraw-Hill, 2006:1749-1783
22. Weiss GB, Klock JC, Richardson HB. Idiopathic thrombocytopenic purpura in the elderly. Lancet 1975;1:411-412
23. Shashaty GG, Rath CE. Idiopathic thrombocytopenic purpura in the elderly. Am J Med Sci 1978;276:263-267
24. McMillan R, Bussel JB, George JN, et al. Self-reported health-related quality of life in adults with chronic immune thrombocytopenic purpura. Am J Hematol 2008;83:150-154
25. Cohen YC, Djulbegovic B, Shamai-Lubovitz O, et al. The bleeding risk and natural history of idiopathic thrombocytopenic purpura in patients with persistent low platelet counts. Arch Intern Med 2000;160:1630-1638 (Pubitemid 30367902)
26. Rodeghiero F. Idiopathic thrombocytopenic purpura: an old disease revisited in the era of evidence-based medicine. Haematologica 2003;88:1081-1087 (Pubitemid 37362537)
27. Pizzuto J, Ambriz R. Therapeutic experience on 934 adults with idiopathic thrombocytopenic purpura: multicentric trial of the cooperative Latin American group on hemostasis and thrombosis. Blood 1984;64:1179-1183 (Pubitemid 15224527)
28. Janatpur K, Holland PV. Noninfectious serious hazards of transfusion. Curr Hematol Rep 2002;1:149-155
29. Langdale LA. Infectious complications of blood transfusions. Infect Dis Clin North Am 1992;6:731-744
30. Zimmer J, Andrè s E, Noel E, et al. Current management of adult idiopathic thrombocytopenic purpura in practice: a cohort study of 201 patients from a single center. Clin Lab Haematol 2004;26:137-142